Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Artiva Biotherapeutics (ARTV) Other Non Operating Income: 2023-2024

Historic Other Non Operating Income for Artiva Biotherapeutics (ARTV) over the last 2 years, with Sep 2024 value amounting to -$977,000.

  • Artiva Biotherapeutics' Other Non Operating Income fell 2054.00% to -$977,000 in Q3 2024 from the same period last year, while for Sep 2024 it was -$4.3 million, marking a year-over-year change of. This contributed to the annual value of -$3.6 million for FY2024, which is 408.77% down from last year.
  • Artiva Biotherapeutics' Other Non Operating Income amounted to -$977,000 in Q3 2024, which was up 58.46% from -$2.4 million recorded in Q2 2024.
  • In the past 5 years, Artiva Biotherapeutics' Other Non Operating Income registered a high of $50,000 during Q3 2023, and its lowest value of -$2.4 million during Q2 2024.
  • Moreover, its 2-year median value for Other Non Operating Income was -$501,000 (2023), whereas its average is -$722,500.
  • Data for Artiva Biotherapeutics' Other Non Operating Income shows a maximum YoY tumbled of 4,255.56% (in 2024) over the last 5 years.
  • Over the past 2 years, Artiva Biotherapeutics' Other Non Operating Income (Quarterly) stood at -$734,000 in 2023, then tumbled by 2,054.00% to -$977,000 in 2024.
  • Its Other Non Operating Income was -$977,000 in Q3 2024, compared to -$2.4 million in Q2 2024 and -$268,000 in Q1 2024.